SIRTLab Corporation, a pioneer in the manipulation of sirtuin proteins for the treatment of severe liver diseases and longevity, today announced the appointment of Michael G. Kauffman , MD, PhD, as Co-Chairman of the Board of Directors and Chief Medical Officer (CMO).
June 22, 2022
· 4 min read